Paddy McMaster
Impact in
-
- Antibiotic Use and Resistance
- Infectious Diseases top 1%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
Papers in
-
- COVID-19 Clinical Research Studies 11
- Tuberculosis Research and Epidemiology 9
- HIV/AIDS Research and Interventions 6
- HIV/AIDS drug development and treatment 2
-
- Antibiotic Use and Resistance 6
- Co-authors
- Frank A Shann (2 shared papers)Graham David Ogle (3 shared papers)Ilomo Hwaihwanje (2 shared papers)Lesley J. Bruce (2 shared papers)Mark T. Young (2 shared papers)Gerard B. Nash (2 shared papers)Robert John Unwin (2 shared papers)Ashley Mark Toye (2 shared papers)
- Journals
- The Lancet (7 papers)Archives of Disease in Childhood (6 papers)The Pediatric Infectious Disease Journal (4 papers)The Lancet Child & Adolescent Health (4 papers)Pediatric Critical Care Medicine (3 papers)
- Partner nations
- United KingdomAustraliaPapua New Guinea
In The Last Decade
Paddy McMaster
54 papers receiving 3.7k citations
Paddy McMaster's Hit Papers
Peers
Comparison fields: 5 of 108
- Applied Microbiology and Biotechnology 292
- Infectious Diseases 2.1k
- Modeling and Simulation 66
- Nephrology 127
- Virology 51
Countries citing papers authored by Paddy McMaster
This map shows the geographic impact of Paddy McMaster's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paddy McMaster with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paddy McMaster more than expected).
Fields of papers citing papers by Paddy McMaster
This network shows the impact of papers produced by Paddy McMaster. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paddy McMaster. The network helps show where Paddy McMaster may publish in the future.
Co-authors
The 25 scholars most cited alongside Paddy McMaster, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 55 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | COVID-19 in children and adolescents in Europe: a multinational, multicentre cohort study Hit paper breakdown → | 2020 | 935 |
| 2 | Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2021 | 411 |
| 3 | Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial Hit paper breakdown → | 2021 | 393 |
| 4 | 2019 | 283 | |
| 5 | Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2022 | 282 |
| 6 | A national consensus management pathway for paediatric inflammatory multisystem syndrome temporally associated with COVID-19 (PIMS-TS): results of a national Delphi process Hit paper breakdown → | 2020 | 260 |
| 7 | Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis Hit paper breakdown → | 2022 | 231 |
| 8 | 2021 | 213 | |
| 9 | 2000 | 148 | |
| 10 | Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2023 | 84 |
| 11 | 2016 | 58 | |
| 12 | 2000 | 41 | |
| 13 | 2018 | 39 | |
| 14 | 2003 | 38 | |
| 15 | 2009 | 33 | |
| 16 | 2023 | 32 | |
| 17 | 2023 | 25 | |
| 18 | 2024 | 24 | |
| 19 | 2002 | 23 | |
| 20 | 2024 | 23 |
About Paddy McMaster
Paddy McMaster is a scholar working on Infectious Diseases, Applied Microbiology and Biotechnology, Virology, Epidemiology and Microbiology, having authored 55 papers that have together received 3.8k indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (11 papers), Tuberculosis Research and Epidemiology (9 papers), HIV/AIDS Research and Interventions (6 papers), Antibiotic Use and Resistance (6 papers), Sepsis Diagnosis and Treatment (4 papers), Kawasaki Disease and Coronary Complications (3 papers), HIV Research and Treatment (2 papers) and HIV/AIDS drug development and treatment (2 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (292 citations), Infectious Diseases (2.1k citations), Modeling and Simulation (66 citations), Nephrology (127 citations) and Virology (51 citations). Paddy McMaster has collaborated with scholars based in United Kingdom, Australia and Papua New Guinea. Frequent co-authors include Frank A Shann, Graham David Ogle, Ilomo Hwaihwanje, Lesley J. Bruce, Mark T. Young, Gerard B. Nash, Robert John Unwin, Ashley Mark Toye, Evelyn Lavu and Oliver Wrong. Their work appears in journals such as The Lancet, Archives of Disease in Childhood, The Pediatric Infectious Disease Journal, The Lancet Child & Adolescent Health and Pediatric Critical Care Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.